Chronic forced swim stress inhibits ultra-low dose morphine-induced hyperalgesia in rats

Ultra-low doses of morphine (UL-morphine) induce hyperalgesia, which is assumed to be mediated by stimulatory G proteins (G&agr;s) signaling pathway. G&agr;s pathway inhibition and chronic stress both attenuate development of tolerance to analgesic effect of morphine. This study evaluated the effect of chronic stress on UL-morphine-induced hyperalgesia to find out if chronic stress interacts with the G&agr;s signaling pathway. Repeated daily forced swim stress was applied to induce chronic stress. UL-morphine (1 μg/kg, intraperitoneal)-induced hyperalgesia was assessed using the tail-flick test on day 6, in male rats that during days 1–5 received different treatments of swim stress, dexamethasone, swim stress following adrenalectomy (ADX) or swim stress after sham operation. Chronic stress by itself induced hyperalgesia in control and sham-operated rats but inhibited UL-morphine-induced hyperalgesia. In ADX animals, chronic stress did not produce hyperalgesia and could not inhibit UL-morphine-induced hyperalgesia. Chronic dexamethasone produced hyperalgesia but did not change the UL-morphine-induced hyperalgesia. Inhibition of UL-morphine hyperalgesia by chronic stress suggests that chronic stress interacts with the G&agr;s signaling pathway, which is responsible for UL-morphine-induced hyperalgesia. The absence of this effect in the ADX-rats or after repetitive dexamethasone administration demonstrates that hypothalamic–pituitary–adrenal (HPA) axis activation is necessary for controlling UL-morphine-induced hyperalgesia. Finally, the interaction of stress with the G&agr;s signaling pathway may provide an explanation for the inhibitory effect of stress on development of tolerance to the analgesic effect of morphine.

[1]  A. Ahmadiani,et al.  Dexamethasone mimics the inhibitory effect of chronic pain on the development of tolerance to morphine analgesia and compensates for morphine induced changes in G proteins gene expression , 2006, Brain Research.

[2]  C. Ghelardini,et al.  Signaling pathway of morphine induced acute thermal hyperalgesia in mice , 2006, PAIN.

[3]  A. Ahmadiani,et al.  STUDY ON THE POSSIBLE SIMILAR MECHANISM OF ULTRA LOW DOSE-INDUCED HYPERALGESIA AND DEVELOPMENT OF TOLERANCE TO ANALGESIA IN MALE RATS: AN STUDY BASED ON THE ROLE OF GS SIGNALING PATHWAY , 2006 .

[4]  K. Shen,et al.  Modulatory effects of Gs-coupled excitatory opioid receptor functions on opioid analgesia, tolerance, and dependence , 1996, Neurochemical Research.

[5]  A. Ahmadiani,et al.  Changes in G proteins genes expression in rat lumbar spinal cord support the inhibitory effect of chronic pain on the development of tolerance to morphine analgesia , 2005, Neuroscience Research.

[6]  M. Khaksari,et al.  Nifedipine potentiates antinociceptive effects of morphine in rats by decreasing hypothalamic pituitary adrenal axis activity , 2005, Pharmacology Biochemistry and Behavior.

[7]  J. Sandkühler,et al.  Opioids and central sensitisation: II. Induction and reversal of hyperalgesia , 2005, European journal of pain.

[8]  A. Ahmadiani,et al.  The Effect of Swim Stress on Morphine Tolerance Development and the Possible Role of Nitric Oxide in this Process , 2005 .

[9]  R. Neubig,et al.  Endogenous Regulator of G Protein Signaling Proteins Suppress Gαo-Dependent, μ-Opioid Agonist-Mediated Adenylyl Cyclase Supersensitization , 2004, Journal of Pharmacology and Experimental Therapeutics.

[10]  E. Nestler,et al.  Historical review: Molecular and cellular mechanisms of opiate and cocaine addiction. , 2004, Trends in pharmacological sciences.

[11]  K. Shen,et al.  Neuraminidase inhibitor, oseltamivir blocks GM1 ganglioside-regulated excitatory opioid receptor-mediated hyperalgesia, enhances opioid analgesia and attenuates tolerance in mice , 2004, Brain Research.

[12]  W. Maixner,et al.  Repeated swim stress increases pain-induced expression of c-Fos in the rat lumbar cord , 2003, Brain Research.

[13]  M. Rhee,et al.  Up-Regulation of Regulator of G Protein Signaling 4 Expression in a Model of Neuropathic Pain and Insensitivity to Morphine , 2003, Journal of Pharmacology and Experimental Therapeutics.

[14]  M. Olmstead,et al.  Paradoxical effects of the opioid antagonist naltrexone on morphine analgesia, tolerance, and reward in rats. , 2002, The Journal of pharmacology and experimental therapeutics.

[15]  K. Shen,et al.  Cholera toxin-B subunit blocks excitatory opioid receptor-mediated hyperalgesic effects in mice, thereby unmasking potent opioid analgesia and attenuating opioid tolerance/dependence , 2001, Brain Research.

[16]  K. Shen,et al.  Acute thermal hyperalgesia elicited by low-dose morphine in normal mice is blocked by ultra-low-dose naltrexone, unmasking potent opioid analgesia , 2001, Brain Research.

[17]  J T Williams,et al.  Cellular and synaptic adaptations mediating opioid dependence. , 2001, Physiological reviews.

[18]  K. Shen,et al.  Enhanced analgesic potency and reduced tolerance of morphine in 129/SvEv mice: evidence for a deficiency in GM1 ganglioside-regulated excitatory opioid receptor functions , 2000, Brain Research.

[19]  K. Shen,et al.  Antagonists of excitatory opioid receptor functions enhance morphine's analgesic potency and attenuate opioid tolerance/dependence liability , 2000, PAIN®.

[20]  R. Melzack,et al.  Long-term patterns of morphine dosage and pain intensity among cancer patients. , 1999, The Hospice journal.

[21]  R. Duman,et al.  Region-Specific Regulation of RGS4 (Regulator of G-Protein–Signaling Protein Type 4) in Brain by Stress and Glucocorticoids: In Vivo and In VitroStudies , 1999, The Journal of Neuroscience.

[22]  C. Barnes,et al.  Dynamic Regulation of RGS2 Suggests a Novel Mechanism in G-Protein Signaling and Neuronal Plasticity , 1998, The Journal of Neuroscience.

[23]  K. Shen,et al.  Modulation of opioid analgesia, tolerance and dependence by Gs-coupled, GM1 ganglioside-regulated opioid receptor functions. , 1998, Trends in pharmacological sciences.

[24]  K. Shen,et al.  Ultra-low doses of naltrexone or etorphine increase morphine's antinociceptive potency and attenuate tolerance/dependence in mice , 1997, Brain Research.

[25]  J. Mogil,et al.  Opioid and Nonopioid Swim Stress-Induced Analgesia: A Parametric Analysis in Mice , 1996, Physiology & Behavior.

[26]  M M Haq,et al.  The tragedy of needless pain. , 1993, The National medical journal of India.

[27]  M. Takahashi,et al.  Anti-stress effect of ginseng on the inhibition of the development of morphine tolerance in stressed mice. , 1992, Japanese journal of pharmacology.

[28]  M. Takahashi,et al.  Footshock- and psychological-stress prevent the development of tolerance to spinal but not supraspinal morphine. , 1991, Japanese Journal of Pharmacology.

[29]  S. Childers,et al.  Opioid receptor-coupled second messenger systems. , 1991, Life sciences.

[30]  K. Shen,et al.  Dual opioid modulation of the action potential duration of mouse dorsal root ganglion neurons in culture , 1989, Brain Research.

[31]  M. Takahashi,et al.  Blockade of the development of analgesic tolerance to morphine by psychological stress through benzodiazepine receptor mediated mechanism. , 1989, Japanese journal of pharmacology.

[32]  M. Takahashi,et al.  Blockade of the development of analgesic tolerance to morphine by concurrent treatment with opioid- but not non-opioid-mediated stress in mice. , 1988, Japanese journal of pharmacology.

[33]  Fred E. D'Amour,et al.  A METHOD FOR DETERMINING LOSS OF PAIN SENSATION , 1941 .